Matches in Wikidata for { <http://www.wikidata.org/entity/Q84375107> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q84375107 description "article scientifique publié en 2012" @default.
- Q84375107 description "artículu científicu espublizáu en xunetu de 2012" @default.
- Q84375107 description "im Juli 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q84375107 description "scientific article published on 02 July 2012" @default.
- Q84375107 description "wetenschappelijk artikel" @default.
- Q84375107 description "наукова стаття, опублікована в липні 2012" @default.
- Q84375107 name "Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19" @default.
- Q84375107 name "Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19" @default.
- Q84375107 type Item @default.
- Q84375107 label "Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19" @default.
- Q84375107 label "Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19" @default.
- Q84375107 prefLabel "Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19" @default.
- Q84375107 prefLabel "Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19" @default.
- Q84375107 P1433 Q84375107-152D17A2-3BCF-42F5-93A9-C9806CAD96AE @default.
- Q84375107 P1476 Q84375107-B0EE1B47-3D6E-4417-9AC7-0505E0A9BCF2 @default.
- Q84375107 P2093 Q84375107-0AFA2F83-BB4A-4052-8888-26D763BD566D @default.
- Q84375107 P2093 Q84375107-B65F5406-D21C-47B8-968D-10CF7D59C2C6 @default.
- Q84375107 P304 Q84375107-B915E579-F70E-45DF-A131-E8C1A2A0EA7B @default.
- Q84375107 P31 Q84375107-A7939D47-AF4F-4A16-A8A7-77AA614056B6 @default.
- Q84375107 P356 Q84375107-A80D066A-3DDE-4130-9977-2AD29AB933C3 @default.
- Q84375107 P433 Q84375107-D716C9BC-54D8-4737-89A6-9741E9F1146B @default.
- Q84375107 P478 Q84375107-0850B73C-80F0-4EDD-BA19-9890522B3992 @default.
- Q84375107 P577 Q84375107-9F6463C6-7FEC-4525-9AC3-BEF11672270A @default.
- Q84375107 P698 Q84375107-36163D09-DDA7-4507-BC5B-8D380FA9C5CA @default.
- Q84375107 P921 Q84375107-49228324-F5DB-4A28-9209-BB103B0EB278 @default.
- Q84375107 P921 Q84375107-628857BB-1B2F-4FD9-9F64-A275D006DD22 @default.
- Q84375107 P356 03007995.2012.703135 @default.
- Q84375107 P698 22697275 @default.
- Q84375107 P1433 Q5195063 @default.
- Q84375107 P1476 "Re: Ulcickas Yood M, Oliveria SA, Cziraky M, et al. Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemia. Curr Med Res Opin 2012, 28(2): 213-19" @default.
- Q84375107 P2093 "Eric Wu" @default.
- Q84375107 P2093 "Lei Chen" @default.
- Q84375107 P304 "1164; author reply 1164-5" @default.
- Q84375107 P31 Q13442814 @default.
- Q84375107 P356 "10.1185/03007995.2012.703135" @default.
- Q84375107 P433 "7" @default.
- Q84375107 P478 "28" @default.
- Q84375107 P577 "2012-07-02T00:00:00Z" @default.
- Q84375107 P698 "22697275" @default.
- Q84375107 P921 Q27139135 @default.
- Q84375107 P921 Q419940 @default.